PDGFRA and hepatocellular carcinoma: It is also reported that LINC00467 can promote the proliferation and invasion of HCC cells through miR-509-3p/PDGFRA, inhibit cell apoptosis, and contribute to Axitinib resistance of hepatocellular carcinoma, which indicates that LINC00467 is a promising biological target for the treatment of liver cancer [8].